Evidence map›Paper›PMID 35232474›Full record

ArticleJournal of pharmaceutical policy and practice2022

Effects of additional context information in prescription drug information sheets on comprehension and risk and efficacy perceptions.

Bridget Kelly, Amie O'Donoghue, Sarah Parvanta, Vanessa Boudewyns, Oluwamurewa Oguntimein, Carla Bann, Sue West, Janice Tzeng, Caroline Chandler, Gabriel Madson and 1 more

Abstract read
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bridget KellyRTI International, 701 13th Street NW, Ste. 750, Washington, DC, 20005, USA. bkelly@rti.org.ORCID http://orcid.org/0000-0002-8661-2694
Amie O'DonoghueCenter for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, USA.
Sarah ParvantaRTI International, 701 13th Street NW, Ste. 750, Washington, DC, 20005, USA.
Vanessa BoudewynsRTI International, 701 13th Street NW, Ste. 750, Washington, DC, 20005, USA.
Oluwamurewa OguntimeinCenter for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, USA.
Carla BannRTI International, 701 13th Street NW, Ste. 750, Washington, DC, 20005, USA.
Sue WestRTI International, 701 13th Street NW, Ste. 750, Washington, DC, 20005, USA.
Janice TzengRTI International, 701 13th Street NW, Ste. 750, Washington, DC, 20005, USA.
Caroline ChandlerRTI International, 701 13th Street NW, Ste. 750, Washington, DC, 20005, USA.
Gabriel MadsonRTI International, 701 13th Street NW, Ste. 750, Washington, DC, 20005, USA.
Lauren McCormackRTI International, 701 13th Street NW, Ste. 750, Washington, DC, 20005, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine how additional explanatory text (context) about drug side effects in a patient medication information handout affected comprehension and perceptions of risk and efficacy.

methodsWe conducted an online experiment with a national sample of 1,119 U.S. adults with rheumatoid arthritis and related conditions, sampled through random-digit dialing, address-based sampling, and online ads. We randomized participants to receive one of several versions of a patient information handout for a fictitious drug, either with or without additional context, then measured comprehension and other outcomes.

resultsAdditional qualitative context about warnings and side effects resulted in lower comprehension of side effect information, but not information about uses of the drug or warnings. The effect of additional context on risk perceptions depended on whether the medication handout was delivered online or through the mail. Those who received a hardcopy of the handout with additional context had higher perceived risk of side effects than those who saw the version without additional context.

conclusionMore clarifying information is not always better and may lead to cognitive overload, inhibiting comprehension. PRACTICE IMPLICATIONS: Additional research should further explore effects of context in online vs. hard-copy formats before practice implications can be determined.

Indexed as

ContextPatient medication informationRisk comprehension

Identifiers

PMID35232474
PMCPMC8887124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.